Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

SEQENS BiotechnologiesSEQENS Biotechnologies
VS
RocheRoche
SEQENS Biotechnologies

SEQENS Biotechnologies

21, Chemin de la Sauvegarde, Écully, 69130, FR

Last Update: 12/05/2026

View Profile
751/1000Fair

At SEQENS Biotechnologies, we offer biosolutions for every application, including high-value active molecules, microorganisms, and specialty enzymes, utilizing both industrial biocatalysis and precision fermentation processes. Our two cutting-edge research and manufactu...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:None
Subsidiaries:32
12-month incidents
0
Known data breaches
0
Attack type number
0
Roche

Roche

Grenzacherstrasse, Switzerland 🇨🇭 , 4070, CH

Last Update: 16/08/2026

View Profile
Between 800 and 849
http://www.roche.com/
836/1000Good

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to ...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:103,689
Subsidiaries:51
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
SEQENS Biotechnologies

SEQENS Biotechnologies

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Roche

Roche

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for SEQENS Biotechnologies in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Roche in 2026.

Incidents

Incident History - SEQENS Biotechnologies (X = Date, Y = Severity)

SEQENS Biotechnologies cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Roche (X = Date, Y = Severity)

Roche cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
SEQENS Biotechnologies

SEQENS Biotechnologies

Incidents
No explicit notable incidents reported.
Roche

Roche

Incidents
No explicit notable incidents reported.

FAQ

Between SEQENS Biotechnologies company and Roche company, which one has the best AI Cybersecurity Score ?
Between SEQENS Biotechnologies company and Roche company, which one has experienced more cyber incidents in the past ?
Between SEQENS Biotechnologies company and Roche company, which one has experienced more cyber incidents this year ?
Between SEQENS Biotechnologies company and Roche company, which one has experienced at least one ransomware attack ?
Between SEQENS Biotechnologies company and Roche company, which one has experienced at least one data breach ?
Between SEQENS Biotechnologies company and Roche company, which one has experienced at least one targeted cyberattack ?
Between SEQENS Biotechnologies company and Roche company, which one has experienced at least one vulnerability ?
Between SEQENS Biotechnologies company and Roche company, which one holds the most compliance certifications ?
Between SEQENS Biotechnologies company and Roche company, which one holds the fewest compliance certifications ?
Between SEQENS Biotechnologies company and Roche company, which one has the most subsidiaries ?
Between SEQENS Biotechnologies company and Roche company, which one has the largest number of employees ?
Between SEQENS Biotechnologies and Roche, which company holds both SOC 2 Type 1 certifications ?
Between SEQENS Biotechnologies and Roche, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - SEQENS Biotechnologies or Roche ?
Which company is PCI DSS compliant - SEQENS Biotechnologies or Roche ?
Between SEQENS Biotechnologies and Roche, which company complies with HIPAA regulations for healthcare data ?
Between SEQENS Biotechnologies and Roche, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-85456
SUMMARY

MOOS-IvP through 24.8.1 fails to properly validate variable names extracted from alog files in the SplitHandler, allowing attackers to write files outside the split directory. Attackers can supply crafted alog files with backslash sequences in variable names to escape the output directory and append to arbitrary files on Windows systems.

PUBLISHED
Date2026-09-03
UPDATED
Date2026-09-03
RISK INFORMATION (Score: 5.5)
CVSS3
Base Score: 5.5
Complexity: LOW
CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:N/I:H/A:N
CVSS4
Base Score: 6.8
Complexity: LOW
CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:P/VC:N/VI:H/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
3.6
EXPLOITABILITY
1.8
CVE-2026-85455
SUMMARY

MOOS core-moos through 10.4.0 contains a buffer over-read vulnerability in CMOOSCommPkt where a four-byte packet triggers out-of-bounds memory access during deserialization. Attackers can open a TCP connection to the MOOSDB port and send a crafted short packet to read memory before authentication.

PUBLISHED
Date2026-09-03
UPDATED
Date2026-09-03
RISK INFORMATION (Score: 8.2)
CVSS3
Base Score: 8.2
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:H
CVSS4
Base Score: 8.8
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
4.2
EXPLOITABILITY
3.9
CVE-2026-85454
SUMMARY

MOOS core-moos through 10.4.0 contains a buffer overflow vulnerability in CMOOSSerialPort::GetTelegram() that writes a NUL terminator one byte past the serial telegram stack buffer. Attackers controlling the serial line can send a full-length telegram to trigger the off-by-one write, corrupting the stack and potentially enabling code execution.

PUBLISHED
Date2026-09-03
UPDATED
Date2026-09-03
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: LOW
CVSS:3.1/AV:P/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:H
CVSS4
Base Score: 5.2
Complexity: LOW
CVSS:4.0/AV:P/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.2
EXPLOITABILITY
0.9
CVE-2026-85453
SUMMARY

MOOS core-moos through 10.4.0 fails to escape database contents when rendering MOOSDB HTTP pages, allowing attackers to inject malicious scripts. Any MOOS publisher can set variable values containing script payloads that execute in the browser of operators viewing the web interface.

PUBLISHED
Date2026-09-03
UPDATED
Date2026-09-03
RISK INFORMATION (Score: 6.1)
CVSS3
Base Score: 6.1
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
CVSS4
Base Score: 5.3
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:L/VA:N/SC:L/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
2.7
EXPLOITABILITY
2.8
CVE-2026-85452
SUMMARY

MOOS ui-moos through 50b9c6c contains a buffer overflow vulnerability in ScopeTabPane.cpp and ScopeGrid.cpp where client and variable names are formatted into fixed 1024-byte buffers using sprintf without length validation. Attackers can supply arbitrarily long MOOS identifiers that overflow the buffers when an operator selects process list entries or pokes variables, enabling code execution.

PUBLISHED
Date2026-09-03
UPDATED
Date2026-09-03
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
CVSS4
Base Score: 8.7
Complexity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
IMPACT SCORE
5.9
EXPLOITABILITY
2.8